These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 7851843)
21. Effect of S-312, a new calcium channel blocker, on the 1,4-dihydropyridine binding sites in porcine basilar blood vessels and rat aortic smooth muscle cells. Mihara S; Fujimoto M Jpn J Pharmacol; 1991 Jul; 56(3):249-59. PubMed ID: 1832726 [TBL] [Abstract][Full Text] [Related]
22. Ca2+ channels in chick neural retina cells characterized by 1,4-dihydropyridine antagonists and activators. Wei XY; Rutledge A; Zhong Q; Ferrante J; Triggle DJ Can J Physiol Pharmacol; 1989 May; 67(5):506-14. PubMed ID: 2548693 [TBL] [Abstract][Full Text] [Related]
23. Effects of dihydropyridine calcium channel blocking drugs on rat brain muscarinic and alpha-adrenergic receptors. Thayer SA; Welcome M; Chhabra A; Fairhurst AS Biochem Pharmacol; 1985 Jan; 34(2):175-80. PubMed ID: 2981533 [TBL] [Abstract][Full Text] [Related]
24. Effects of aranidipine, a novel calcium channel blocker, on mechanical responses of the isolated rat portal vein: comparison with typical calcium channel blockers and potassium channel openers. Okumura K; Ichihara K; Nagasaka M J Cardiovasc Pharmacol; 1997 Feb; 29(2):209-15. PubMed ID: 9057070 [TBL] [Abstract][Full Text] [Related]
25. Effects of calcium channel blockers and hydralazine on plasma glucose levels in streptozotocin-induced diabetic rats in vivo. Sunaga K; Ogihara M Jpn J Pharmacol; 1990 Mar; 52(3):449-55. PubMed ID: 2332939 [TBL] [Abstract][Full Text] [Related]
26. Cardiac versus vascular effects of a new dihydropyridine derivative, CV-4093. In vitro comparison with other calcium antagonists. Nakaya H; Hattori Y; Nakao Y; Kanno M Eur J Pharmacol; 1988 Jan; 146(1):35-43. PubMed ID: 3350058 [TBL] [Abstract][Full Text] [Related]
27. Different antagonism of the positive chronotropic and inotropic responses of the isolated, blood-perfused dog atrium to Bay k 8644 by nicardipine and verapamil. Furukawa Y; Ogiwara Y; Akahane K; Chiba S Eur J Pharmacol; 1988 Nov; 156(2):231-7. PubMed ID: 2467822 [TBL] [Abstract][Full Text] [Related]
28. The effects of dihydropyridine calcium channel modulators on pentylenetetrazole convulsions. O'Neill SK; Bolger GT Brain Res Bull; 1990 Jul; 25(1):211-4. PubMed ID: 1698518 [TBL] [Abstract][Full Text] [Related]
29. Ca2+ channel modulation alters halothane-induced depression of ventricular myocytes. Kanaya N; Matsumoto M; Kawana S; Tsuchida H; Kimura H; Miyamoto A; Ohshika H; Namiki A Can J Anaesth; 1998 Jun; 45(6):584-91. PubMed ID: 9669017 [TBL] [Abstract][Full Text] [Related]
30. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium. Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975 [TBL] [Abstract][Full Text] [Related]
31. Differential effects of L-type calcium channel blockers and stimulants on naloxone-precipitated withdrawal in mice acutely dependent on morphine. Barrios M; Baeyens JM Psychopharmacology (Berl); 1991; 104(3):397-403. PubMed ID: 1718013 [TBL] [Abstract][Full Text] [Related]
32. Effect of calcium channel blockers on platelet GPIIb-IIIa as a calcium channel in liposomes: comparison with effects on the intact platelet. Rybak ME; Renzulli LA Thromb Haemost; 1992 Jan; 67(1):131-6. PubMed ID: 1319614 [TBL] [Abstract][Full Text] [Related]
33. Effects of calcium channel antagonists and facilitators on beating of primary cultures of embryonic chick heart cells. Patmore L; Duncan GP Br J Pharmacol; 1988 Nov; 95(3):771-6. PubMed ID: 3207992 [TBL] [Abstract][Full Text] [Related]
34. Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A. Ma B; Prueksaritanont T; Lin JH Drug Metab Dispos; 2000 Feb; 28(2):125-30. PubMed ID: 10640508 [TBL] [Abstract][Full Text] [Related]
36. The effect of calcium-blockers nicardipine, darodipine, PN-200-110 and nifedipine on insulin release from isolated rat pancreatic islets. Al-Mahmood HA; el-Khatim MS; Gumaa KA; Thulesius O Acta Physiol Scand; 1986 Feb; 126(2):295-8. PubMed ID: 2939690 [TBL] [Abstract][Full Text] [Related]
37. Vascular selectivity of seven prototype calcium antagonists: a study at the single cell level. Pérez-Vizcaíno F; Tamargo J; Hof RP; Rüegg UT J Cardiovasc Pharmacol; 1993 Nov; 22(5):768-75. PubMed ID: 7506331 [TBL] [Abstract][Full Text] [Related]
38. Increase in plasma propranolol caused by nicardipine is dependent on the delivery rate of propranolol. Vercruysse I; Massart DL; Dupont AG Eur J Clin Pharmacol; 1995; 49(1-2):121-5. PubMed ID: 8751033 [TBL] [Abstract][Full Text] [Related]
39. Inhibitory effect of calcium channel blockers on human mesangial cell growth: evidence for actions independent of L-type Ca2+ channels. Orth SR; Nobiling R; Bönisch S; Ritz E Kidney Int; 1996 Mar; 49(3):868-79. PubMed ID: 8648932 [TBL] [Abstract][Full Text] [Related]
40. Effects of three different L-type Ca2+ entry blockers on airway constriction induced by muscarinic receptor stimulation. Hirota K; Hashiba E; Yoshioka H; Kabara S; Matsuki A Br J Anaesth; 2003 May; 90(5):671-5. PubMed ID: 12697597 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]